Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Small-molecule glues selectively restrict deubiquitylase activity and inflammatory signaling

A new class of small molecular ‘glues’ selectively inhibit the BRISC deubiquitylase complex by stabilizing it in an inactive dimeric conformation. These compounds reduce inflammatory signaling by preventing deubiquitylation of an interferon receptor, and thereby offer a promising avenue for the treatment of type I interferon-driven diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: BRISC structure in complex with molecular glues.

References

  1. Clague, M. J., Urbé, S. & Komander, D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat. Rev. Mol. Cell Biol. 20, 338–352 (2019). This comprehensive review summarizes the functional roles of DUBs.

    Article  CAS  PubMed  Google Scholar 

  2. Zheng, H. et al. A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses. Cell Rep. 5, 180–193 (2013). This article identifies the BRISC complex as a regulator of interferon signaling.

    Article  CAS  PubMed  Google Scholar 

  3. Zeqiraj, E. et al. Higher-order assembly of BRCC36-KIAA0157 is required for DUB activity and biological function. Mol. Cell 59, 970–983 (2015). This article describes the crystal structure of a minimally active DUB complex and the crucial role of allostery in BRCC36 function.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Walden, M. et al. Metabolic control of BRISC-SHMT2 assembly regulates immune signalling. Nature 570, 194–199 (2019). This article describes the cryo-EM structure of a full BRISC complex with its targeting partner SHMT2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Schreiber, S. L. The rise of molecular glues. Cell 184, 3–9 (2021). This article explores the 30-year evolution of molecular glues, highlighting their transformative impact on drug development.

    Article  CAS  PubMed  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

E.Z. and F.C. used ChatGPT to help prepare their contribution to this Research Briefing.

This is a summary of: Chandler, F. et al. Molecular glues that inhibit deubiquitylase activity and inflammatory signaling. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-025-01517-5 (2025).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Small-molecule glues selectively restrict deubiquitylase activity and inflammatory signaling. Nat Struct Mol Biol 32, 1592–1593 (2025). https://doi.org/10.1038/s41594-025-01518-4

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41594-025-01518-4

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research